Search

Technology can be a pain in the neck, leading to what’s known as “tech neck,” chronic pain that results from prolonged use of mobile phones, tablets, and other electronic devices.

Switching what the powerhouses of heart cells consume for energy could help the heart regenerate when cells die.

Brain cancer patients in the coming years may not need to go under the knife to help doctors determine the best treatment for their tumors.

Artificial intelligence can help cancer patients start their radiation therapy sooner – and thereby decrease the odds of the cancer spreading – by instantly translating complex clinical data into an optimal plan of attack.

UT Southwestern Medical Center’s Harold C. Simmons Comprehensive Cancer Center is among the first in the nation and the first in Texas to offer radiation treatments using a new technology that combines positron emission tomography (PET) imaging with radiotherapy to precisely treat bone and lung cancers.

On a Thursday morning in Dallas, Fiona Strasserking, M.D., chats with her UT Southwestern colleague while internal medicine residents from the University of Zambia log on to their Zoom call. Rafic Berbarie, M.D., Associate Professor in UTSW’s Division of Cardiology, is today’s guest lecturer and the topic is “Evaluation of Chest Pain.” He’ll cover everything from chronic angina to myocardial infarction.

Interactions among microorganisms within the human gut may be associated with increased anxiety levels in people with depression, according to research led by UT Southwestern Medical Center.

More than a dozen UT Southwestern Medical Center scientists are included on the 2023 Highly Cited Researchers list, which recognizes the top 1% of researchers from around the world who have demonstrated significant and broad influence in their chosen field or fields of research.

Measuring blood pressure while patients are standing rather than sitting may improve the accuracy of readings, UT Southwestern Medical Center researchers report.

Although hundreds of thousands of patients with atherosclerotic cardiovascular disease (ASCVD) are eligible for high-intensity statin therapy, most are not using the drugs, UT Southwestern Medical Center researchers report.